Gfi-1 is the transcriptional repressor of SOCS1 in acute myeloid leukemia cells

Journal of Leukocyte Biology

Volumn 95, Issue 1, 2014, Pages 105-115

  Lee, Ming Cheng ^a   Kuo, Yuan Yeh ^b   Chou, Wen Chien ^a,c   Hou, Hsin An ^a,b   Hsiao, Michael ^d   Tien, Hwei Fang ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d GENOMICS RESEARCH CENTER   (Taiwan)

Author keywords

G9a; H3K9 methylation; SUV39H1

Indexed keywords

CHETOCIN; DNA; HISTONE H3; HISTONE METHYLTRANSFERASE; MESSENGER RNA; METHYLTRANSFERASE INHIBITOR; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; STAT5 PROTEIN; STAT5A PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GFI 1; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; GFI1 PROTEIN, HUMAN; HISTONE; PIPERAZINE DERIVATIVE; REPRESSOR PROTEIN; SOCS1 PROTEIN, HUMAN; SUPPRESSOR OF CYTOKINE SIGNALING;

ACUTE GRANULOCYTIC LEUKEMIA; APOPTOSIS; ARTICLE; BINDING SITE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA MODIFICATION; GENE REPRESSION; GENE SEQUENCE; GENE SILENCING; GENETIC TRANSCRIPTION; HISTONE METHYLATION; HUMAN; HUMAN CELL; LEUKEMIA CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; WESTERN BLOTTING; DRUG EFFECT; G9A; GENE EXPRESSION REGULATION; GENETICS; H3K9 METHYLATION; METABOLISM; METHYLATION; PROTEIN BINDING; RNA INTERFERENCE; SUV39H1; TRANSCRIPTION INITIATION; TUMOR CELL LINE;

G9A; H3K9 METHYLATION; SUV39H1;

APOPTOSIS; CELL LINE, TUMOR; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, LEUKEMIC; GENE KNOCKDOWN TECHNIQUES; HISTONES; HUMANS; LEUKEMIA, MYELOID, ACUTE; METHYLATION; PIPERAZINES; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; REPRESSOR PROTEINS; RNA INTERFERENCE; STAT5 TRANSCRIPTION FACTOR; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION;

EID: 84897018423     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.0912475     Document Type: Article

References (34)

1. Jones, P. A., Baylin, S. B. (2007) The epigenomics of cancer. Cell 128, 683-692.
2. Copeland, R. A., Solomon, M. E., Richon, V. M. (2009) Protein methyltransferases as a target class for drug discovery. Nat. Rev. Drug Discov. 8, 724-732.
3. Rius, M., Lyko, F. (2012) Epigenetic cancer therapy: rationales, targets and drugs. Oncogene 31, 4257-4265.
4. Greiner, D., Bonaldi, T., Eskeland, R., Roemer, E., Imhof, A. (2005) Identification of a specific inhibitor of the histone methyltransferase SU(VAR)3-9. Nat. Chem. Biol. 1, 143-145.
5. Cherrier, T., Suzanne, S., Redel, L., Calao, M., Marban, C., Samah, B., Mukerjee, R., Schwartz, C., Gras, G., Sawaya, B. E., Zeichner, S. L., Aunis, D., Van Lint, C., Rohr, O. (2009) p21(WAF1) gene promoter is epigenetically silenced by CTIP2 and SUV39H1. Oncogene 28, 3380-3389.
6. Lakshmikuttyamma, A., Scott, S. A., DeCoteau, J. F., Geyer, C. R. (2010) Reexpression of epigenetically silenced AML tumor suppressor genes by SUV39H1 inhibition. Oncogene 29, 576-588.
7. Muller-Tidow, C., Klein, H. U., Hascher, A., Isken, F., Tickenbrock, L., Thoennissen, N., Agrawal-Singh, S., Tschanter, P., Disselhoff, C., Wang, Y., Becker, A., Thiede, C., Ehninger, G., zur Stadt, U., Koschmieder, S., Seidl, M., Müller, F. U., Schmitz, W., Schlenke, P., McClelland, M., Berdel, W. E., Dugas, M., Serve, H., Study Alliance Leukemia (2010) Profiling of histone H3 lysine 9 trimethylation levels predicts transcription factor activity and survival in acute myeloid leukemia. Blood 116, 3564-3571.
8. Yoshikawa, H., Matsubara, K., Qian, G. S., Jackson, P., Groopman, J. D., Manning, J. E., Harris, C. C., Herman, J. G. (2001) SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity. Nat. Genet. 28, 29-35.
9. Cooney, R. N. (2002) Suppressors of cytokine signaling (SOCS): inhibitors of the JAK/STAT pathway. Shock 17, 83-90.
10. Gregorieff, A., Pyronnet, S., Sonenberg, N., Veillette, A. (2000) Regulation of SOCS-1 expression by translational repression. J. Biol. Chem. 275, 21596-21604.
11. Chen, X. P., Losman, J. A., Cowan, S., Donahue, E., Fay, S., Vuong, B. Q., Nawijn, M. C., Capece, D., Cohan, V. L., Rothman, P. (2002) Pim serine/threonine kinases regulate the stability of Socs-1 protein. Proc. Natl. Acad. Sci. USA 99, 2175-2180.
12. Travagli, J., Letourneur, M., Bertoglio, J., Pierre, J. (2004) STAT6 and Ets-1 form a stable complex that modulates Socs-1 expression by interleukin-4 in keratinocytes. J. Biol. Chem. 279, 35183-35192.
13. Jegalian, A. G., Wu, H. (2002) Regulation of Socs gene expression by the proto-oncoprotein GFI-1B: two routes for STAT5 target gene induction by erythropoietin. J. Biol. Chem. 277, 2345-2352.
14. Zhang, J., Li, H., Yu, J. P., Wang, S. E., Ren, X. B. (2012) Role of SOCS1 in tumor progression and therapeutic application. Int. J. Cancer 130, 1971-1980.
15. Zweidler-Mckay, P. A., Grimes, H. L., Flubacher, M. M., Tsichlis, P. N. (1996) Gfi-1 encodes a nuclear zinc finger protein that binds DNA and functions as a transcriptional repressor. Mol. Cell. Biol. 16, 4024-4034.
16. Van der Meer, L. T., Jansen, J. H., van der Reijden, B. A. (2010) Gfi1 and Gfi1b: key regulators of hematopoiesis. Leukemia 24, 1834-1843.
17. Moignard, V., Macaulay, I. C., Swiers, G., Buettner, F., Schutte, J., Calero-Nieto, F. J., Kinston, S., Joshi, A., Hannah, R., Theis, F. J., Jacobsen, S. E., de Bruijn, M. F., Göttgens, B. (2013) Characterization of transcriptional networks in blood stem and progenitor cells using highthroughput single-cell gene expression analysis. Nat. Cell Biol. 15, 363-372.
18. Keinanen, M., Griffin, J. D., Bloomfield, C. D., Machnicki, J., de la Chapelle, A. (1988) Clonal chromosomal abnormalities showing multiple-cell-lineage involvement in acute myeloid leukemia. N. Engl. J. Med. 318, 1153-1158.
19. Liu, Q., Dong, F. (2012) Gfi-1 inhibits the expression of eosinophil major basic protein (MBP) during G-CSF-induced neutrophilic differentiation. Int. J. Hematol. 95, 640-647.
20. Kato, Y., Iwama, A., Tadokoro, Y., Shimoda, K., Minoguchi, M., Akira, S., Tanaka, M., Miyajima, A., Kitamura, T., Nakauchi, H. (2005) Selective activation of STAT5 unveils its role in stem cell self-renewal in normal and leukemic hematopoiesis. J. Exp. Med. 202, 169-179.
21. Basu, S., Liu, Q., Qiu, Y., Dong, F. (2009) Gfi-1 represses CDKN2B encoding p15INK4B through interaction with Miz-1. Proc. Natl. Acad. Sci. USA 106, 1433-1438.
22. Person, R. E., Li, F. Q., Duan, Z., Benson, K. F., Wechsler, J., Papadaki, H. A., Eliopoulos, G., Kaufman, C., Bertolone, S. J., Nakamoto, B., Papayannopoulou, T., Grimes, H. L., Horwitz, M. (2003) Mutations in proto-oncogene GFI1 cause human neutropenia and target ELA2. Nat. Genet. 34, 308-312.
23. Hayslip, J., Montero, A. (2006) Tumor suppressor gene methylation in follicular lymphoma: a comprehensive review. Mol. Cancer 5, 44.
24. Kondo, Y., Shen, L., Issa, J. P. (2003) Critical role of histone methylation in tumor suppressor gene silencing in colorectal cancer. Mol. Cell. Biol. 23, 206-215.
25. Bachman, K. E., Park, B. H., Rhee, I., Rajagopalan, H., Herman, J. G., Baylin, S. B., Kinzler, K. W., Vogelstein, B. (2003) Histone modifications and silencing prior to DNA methylation of a tumor suppressor gene. Cancer Cell 3, 89-95.
26. Fritsch, L., Robin, P., Mathieu, J. R., Souidi, M., Hinaux, H., Rougeulle, C., Harel-Bellan, A., Ameyar-Zazoua, M., Ait-Si-Ali, S. (2010) A subset of the histone H3 lysine 9 methyltransferases Suv39h1, G9a, GLP, and SETDB1 participate in a multimeric complex. Mol. Cell. 37, 46-56.
27. Zeng, H., Yucel, R., Kosan, C., Klein-Hitpass, L., Moroy, T. (2004) Transcription factor Gfi1 regulates self-renewal and engraftment of hematopoietic stem cells. EMBO J. 23, 4116-4125.
28. Garcon, L., Lacout, C., Svinartchouk, F., Le Couedic, J. P., Villeval, J. L., Vainchenker, W., Dumenil, D. (2005) Gfi-1B plays a critical role in terminal differentiation of normal and transformed erythroid progenitor cells. Blood 105, 1448-1455.
29. Moroy, T., Khandanpour, C. (2011) Growth factor independence 1 (Gfi1) as a regulator of lymphocyte development and activation. Semin. Immunol. 23, 368-378.
30. Zhu, J., Jankovic, D., Grinberg, A., Guo, L., Paul, W. E. (2006) Gfi-1 plays an important role in IL-2-mediated Th2 cell expansion. Proc. Natl. Acad. Sci. USA 103, 18214-18219.
31. Schmidt, T., Karsunky, H., Gau, E., Zevnik, B., Elsasser, H. P., Moroy, T. (1998) Zinc finger protein GFI-1 has low oncogenic potential but cooperates strongly with pim and myc genes in T-cell lymphomagenesis. Oncogene 17, 2661-2667.
32. Duan, Z., Zarebski, A., Montoya-Durango, D., Grimes, H. L., Horwitz, M. (2005) Gfi1 coordinates epigenetic repression of p21Cip/WAF1 by recruitment of histone lysine methyltransferase G9a and histone deacetylase 1. Mol. Cell. Biol. 25, 10338-10351.
33. Steensma, D. P., McClure, R. F., Karp, J. E., Tefferi, A., Lasho, T. L., Powell, H. L., DeWald, G. W., Kaufmann, S. H. (2006) JAK2 V617F is a rare finding in de novo acute myeloid leukemia, but STAT3 activation is common and remains unexplained. Leukemia 20, 971-978.
34. Kondo, Y., Shen, L., Ahmed, S., Boumber, Y., Sekido, Y., Haddad, B. R., Issa, J. P. (2008) Downregulation of histone H3 lysine 9 methyltransferase G9a induces centrosome disruption and chromosome instability in cancer cells. PLoS One 3, e2037.